Nonchemotherapy drug‐induced cytopenias: A cost‐of‐illness study using the microcosting methodology based on real‐world data
Our study showed that the use of healthcare services and costs caused by nonchemotherapy drugs are considerable. Proactive strategies to manage and prevent drug-induced cytopenias should be considered.
Authors
- Valentina Marinković (ORCID: https://orcid.org/0000-0001-6745-5059)
- Slobodan Јаnkovic (ORCID: https://orcid.org/0000-0002-1519-8828)
- Dragana Lakić (ORCID: https://orcid.org/0000-0002-6861-3888)
- Ivana Stević (ORCID: https://orcid.org/0000-0001-8880-7092)
- Nemanja Petrović (ORCID: https://orcid.org/0000-0001-5592-5084)
- Nataša Čanak‐Baltić
Institutions
- University of Kragujevac (RS)
- University of Belgrade (RS)
- Clinical Centre of Kragujevac (RS)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1002/bcp.70122
- Citations
- 1
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.80